Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials

Y. Xiao, F. Yin, Feng Ming Kong, J. Yue, J. Galvin

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.

Original languageEnglish (US)
Title of host publicationWorld Congress on Medical Physics and Biomedical Engineering
Pages2284-2287
Number of pages4
DOIs
StatePublished - Apr 16 2013
EventWorld Congress on Medical Physics and Biomedical Engineering - Beijing, China
Duration: May 26 2012May 31 2012

Publication series

NameIFMBE Proceedings
Volume39 IFMBE
ISSN (Print)1680-0737

Other

OtherWorld Congress on Medical Physics and Biomedical Engineering
CountryChina
CityBeijing
Period5/26/125/31/12

Fingerprint

Radiotherapy
Accreditation
Surgery
Dosimetry
Costs

Keywords

  • NSCLC
  • SBRT
  • Surgery
  • clinical trials
  • quality

ASJC Scopus subject areas

  • Bioengineering
  • Biomedical Engineering

Cite this

Xiao, Y., Yin, F., Kong, F. M., Yue, J., & Galvin, J. (2013). Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. In World Congress on Medical Physics and Biomedical Engineering (pp. 2284-2287). (IFMBE Proceedings; Vol. 39 IFMBE). https://doi.org/10.1007/978-3-642-29305-4_599

Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. / Xiao, Y.; Yin, F.; Kong, Feng Ming; Yue, J.; Galvin, J.

World Congress on Medical Physics and Biomedical Engineering. 2013. p. 2284-2287 (IFMBE Proceedings; Vol. 39 IFMBE).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Xiao, Y, Yin, F, Kong, FM, Yue, J & Galvin, J 2013, Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. in World Congress on Medical Physics and Biomedical Engineering. IFMBE Proceedings, vol. 39 IFMBE, pp. 2284-2287, World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 5/26/12. https://doi.org/10.1007/978-3-642-29305-4_599
Xiao Y, Yin F, Kong FM, Yue J, Galvin J. Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. In World Congress on Medical Physics and Biomedical Engineering. 2013. p. 2284-2287. (IFMBE Proceedings). https://doi.org/10.1007/978-3-642-29305-4_599
Xiao, Y. ; Yin, F. ; Kong, Feng Ming ; Yue, J. ; Galvin, J. / Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials. World Congress on Medical Physics and Biomedical Engineering. 2013. pp. 2284-2287 (IFMBE Proceedings).
@inproceedings{6a47a0a8b55b4a779b9505f48abda5c3,
title = "Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials",
abstract = "Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.",
keywords = "NSCLC, SBRT, Surgery, clinical trials, quality",
author = "Y. Xiao and F. Yin and Kong, {Feng Ming} and J. Yue and J. Galvin",
year = "2013",
month = "4",
day = "16",
doi = "10.1007/978-3-642-29305-4_599",
language = "English (US)",
isbn = "9783642293047",
series = "IFMBE Proceedings",
pages = "2284--2287",
booktitle = "World Congress on Medical Physics and Biomedical Engineering",

}

TY - GEN

T1 - Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials

AU - Xiao, Y.

AU - Yin, F.

AU - Kong, Feng Ming

AU - Yue, J.

AU - Galvin, J.

PY - 2013/4/16

Y1 - 2013/4/16

N2 - Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.

AB - Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies.

KW - NSCLC

KW - SBRT

KW - Surgery

KW - clinical trials

KW - quality

UR - http://www.scopus.com/inward/record.url?scp=84876020076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876020076&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-29305-4_599

DO - 10.1007/978-3-642-29305-4_599

M3 - Conference contribution

AN - SCOPUS:84876020076

SN - 9783642293047

T3 - IFMBE Proceedings

SP - 2284

EP - 2287

BT - World Congress on Medical Physics and Biomedical Engineering

ER -